Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christy M Finke

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
American Journal of Hematology|June 16, 2011
Infrequent occurrence of MPL exon 10 mutations in polycythemia vera and post-polycythemia vera myelofibrosisAnimesh Pardanani, Terra L Lasho, Christy M Finke, et al.
American Journal of Hematology|February 10, 2018
Mayo CALR mutation type classification guide using alpha helix propensityTerra L Lasho, Christy M Finke, Alexander Tischer, et al.
American Journal of Hematology|December 15, 2015
Targeted next generation sequencing of PDGFRB rearranged myeloid neoplasms with monocytosisMrinal M Patnaik, Terra L Lasho, Christy M Finke, et al.
American Journal of Hematology|September 12, 2012
Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosisRakhee Vaidya, Naseema Gangat, Thitina Jimma, et al.
Annals of Hematology|April 24, 2016
Pruritus in primary myelofibrosis: management options in the era of JAK inhibitorsBrianna E Vaa, Ayalew Tefferi, Naseema Gangat, et al.
Leukemia|March 15, 2018
U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctionsAyalew Tefferi, Christy M Finke, Terra L Lasho, et al.
American Journal of Hematology|November 15, 2011
Pruritus in primary myelofibrosis: clinical and laboratory correlatesBrianna E Vaa, Alexandra P Wolanskyj, Lindsey Roeker, et al.
Blood Cancer Journal|February 17, 2018
CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survivalNatasha Szuber, Christy M Finke, Terra L Lasho, et al.
Blood|January 9, 2010
WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adultsAnimesh Pardanani, Ken-Hong Lim, Terra L Lasho, et al.
Blood Cancer Journal|March 14, 2018
Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasmsTerra L Lasho, Rangit Vallapureddy, Christy M Finke, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
American Journal of Hematology|June 16, 2011
Infrequent occurrence of MPL exon 10 mutations in polycythemia vera and post-polycythemia vera myelofibrosisAnimesh Pardanani, Terra L Lasho, Christy M Finke, et al.
American Journal of Hematology|February 10, 2018
Mayo CALR mutation type classification guide using alpha helix propensityTerra L Lasho, Christy M Finke, Alexander Tischer, et al.
American Journal of Hematology|December 15, 2015
Targeted next generation sequencing of PDGFRB rearranged myeloid neoplasms with monocytosisMrinal M Patnaik, Terra L Lasho, Christy M Finke, et al.
American Journal of Hematology|September 12, 2012
Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosisRakhee Vaidya, Naseema Gangat, Thitina Jimma, et al.
Annals of Hematology|April 24, 2016
Pruritus in primary myelofibrosis: management options in the era of JAK inhibitorsBrianna E Vaa, Ayalew Tefferi, Naseema Gangat, et al.
Leukemia|March 15, 2018
U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctionsAyalew Tefferi, Christy M Finke, Terra L Lasho, et al.
American Journal of Hematology|November 15, 2011
Pruritus in primary myelofibrosis: clinical and laboratory correlatesBrianna E Vaa, Alexandra P Wolanskyj, Lindsey Roeker, et al.
Blood Cancer Journal|February 17, 2018
CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survivalNatasha Szuber, Christy M Finke, Terra L Lasho, et al.
Blood|January 9, 2010
WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adultsAnimesh Pardanani, Ken-Hong Lim, Terra L Lasho, et al.
Blood Cancer Journal|March 14, 2018
Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasmsTerra L Lasho, Rangit Vallapureddy, Christy M Finke, et al.
Pageof 7